Equity Distribution for NEUROCRINE BIOSCIENCES Inc
Ticker | NBIX |
FIGI | BBG000GJS7C1 |
CUSIP | 64125C109 |
Sector | Healthcare |
Equity Type | Common Stock |
No. Companies Holding this Equity | 556 / 8.1% |
Percentage held by institutional investors | 91.9% |
About
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. Wikipedia